Inhaled Nitric Oxide Delivery Systems Market - Historic Data (2019-2024), Global Trends 2025, Growth Forecasts 2037
Inhaled Nitric Oxide Delivery Systems Market in 2025 is assessed at USD 382.26 million. The global market size was worth more than USD 368.41 million in 2024 and is poised to witness a CAGR of over 4.7%, crossing USD 669.33 million revenue by 2037. North America is projected to reach USD 234.27 million by 2037, fueled by COPD prevalence and growing INO therapy adoption.
Hospital admission is required in over 50% of patients with asthma. The key factor fuelling the growth of the global market is increased R&D efforts which have led to novel applications for this technology in the healthcare sector. Moreover, the demand for inhaled nitric oxide delivery systemss worldwide is driven by an aging population with reduced lung function.
The market is growing as more and more people are using nitric oxide inhalation, a minimally invasive treatment. In a study conducted in 2020, inhaled nitric oxide has been shown to be effective in treating SARSCoV2 infection. It is also an effective treatment for COVID19 patients, as with conventional medicines. As a result, demand for inhaled nitric oxide delivery systemss increased during the pandemic.
